Recursion Pharmaceuticals, Inc. (BIVA:RXRX) IPO
IPO
Priced at US$18.00 a share on Apr 15, 2021.
- Price
- US$18.00 a share
- Shares offered
- 24,242,424 shares of Class A common stock
- Offering size
- US$436.4 million
- Underwriters' option
- Up to 3,636,363 more shares
- Underwriters
- Goldman Sachs & Co. LLC, J.P. Morgan, BofA Securities, SVB Leerink, Allen & Company LLC, KeyBanc Capital Markets · In the order on the cover
- Shares delivered
- On or about Apr 20, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jan 26, 2021 |
| Filed publicly | Mar 22, 2021 |
| Amended twice | Newest Apr 15, 2021 |
| Shares registered with an exchange | Apr 12, 2021 |
| Declared effective by the SEC | Apr 15, 2021 |
| Final prospectus, with the price | Apr 16, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Apr 16, 2021 |
| EFFECT · Notice that a registration is effective | Apr 15, 2021 |
| S-1MEF · Registration of more shares for the same offering | Apr 15, 2021 |
| CERT · Exchange's certificate of listing | Apr 15, 2021 |
| S-1/A · Registration statement, amended | Apr 15, 2021 |
| CORRESP · Letter to the SEC | Apr 13, 2021 |
| CORRESP · Letter to the SEC | Apr 13, 2021 |
| S-1/A · Registration statement, amended | Apr 12, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Apr 12, 2021 |
| CORRESP · Letter to the SEC | Mar 22, 2021 |
| S-1 · Registration statement | Mar 22, 2021 |
| UPLOAD · Letter from the SEC | Mar 19, 2021 |
| DRSLTR · Letter to the SEC with a draft | Mar 3, 2021 |
| DRS/A · Draft registration statement, amended | Mar 3, 2021 |
| UPLOAD · Letter from the SEC | Feb 22, 2021 |
| DRS · Draft registration statement | Jan 26, 2021 |
From the cover of the final prospectus (424B4) filed Apr 16, 2021